Medicilon delivers Green Chemistry Solutions for drug development

Environmental pollution and energy waste causes the destruction of ecosystems, extinction of species and global warming, leading to serious and long-lasting global challenges.  To mitigate these challenges, green chemistry approaches are being developed and introduced into chemical and pharmaceutical industries to deliver improved environmental sustainability into drug development and manufacturing processes.

green chemistry

Green chemistry involves the design of processes and chemical products to reduce the use and generation of hazardous substances as far as possible, addressing synthesis procedures according to innovative principles. Medicilon’s approaches contribute to the sustainability of chemical processes, saving energy in production, lowering toxicity of reagents and final products, reducing damage to the environment and human health and decreasing climate change to drive the rational use of natural resources.

Medicilon applies green chemistry across the life cycle of chemical products, from design and manufacture to use and disposal. Green chemistry research and tools help Medicilon to create processes and products that are healthier and more sustainable. Medicilon actively develops new technologies platforms, integrating emerging methods of green chemistry into its services, using photoredox chemistry, electrochemistry, catalyst screening and continuous reactions, to provide our customers with high-quality green solutions.  We apply these platforms and green principles routinely to all of our customer projects, regardless of size, cost and duration.

If you would like to read more about Medicilon’s green chemistry approaches please go to Green Chemistry Platform | Medicilon Platforms

Medicilon, a leading partner for drug development:   

Medicilon is a leading full-service contract research organization providing comprehensive preclinical R&D development capabilities to our clients for over 19 years.  With offices in the UK, China and the USA, we comply with the requirements of global regulatory agencies including the FDA and supply candidates, drug product and data to support regulatory applications globally. We can deliver your projects needs from small preliminary fee for service studies all the way to multiple FTE, fully integrated discovery projects, portfolio contracts and manufacture.

Medicilons Chemistry potential:   Our chemistry department works closely with our GMP manufacturing expert team and is one of Medicilons major strengths. We have a large and highly experienced team of over 1200 Medicinal, Synthetic, & Analytical chemists with over 13,000 M2 of lab space and with active plans to grow to over 28,000 M2. Medicilon also has over 250 process and formulation development chemists working in over 10,000 M2 of lab space. We offer a wide range of chemistry services including hit identification, compound design, screening, ADMET, PK/PD, candidate selection, process and formulation development, GLP toxicology evaluation and GMP manufacture and we have developed significant experience in green chemistry.

Find out more here: www.medicilon.com



Looking for something specific?